Refreshed just now
STAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in China
Why it’s here: House Select Committee on China investigation into big pharma clinical trials in China, tied to biotech national security and BIOSECURE-style China competition concerns, is a live federal policy fight.
Trace across the boardItem
2d agoSTATSTAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in ChinaThis STAT Pharmalittle roundup notes that major pharmaceutical firms are using AI for molecule design and early-stage work, and that several large drugmakers pledged to the House China committee to avoid new Xinjiang and military-affiliated trial sites. Biotech17 linked
Coverage
1 outlets · first seen 2d agoConnected
11 links- NewsSTAT+: Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and moreBoth involve Eli Lilly, Merck, AbbVie
- NewsEx-Nvidia CEO should testify before Congress, Rep. John Moolenaar saysBoth involve China, House Select Committee on Strategic Competition between the United States and the Chinese Communist Party
- NewsHouse Panel Calls for Ban on FAA Certification of Chinese AircraftBoth involve House Select Committee on Strategic Competition between the United States and the Chinese Communist Party
- NewsSTAT+: Lawmakers want U.S. biotech to outcompete ChinaBoth involve Merck
- HillSelect Committee on China and Congressional-Executive Commission on China Back DHS's Enforcement of UFLPABoth involve House Select Committee on Strategic Competition between the United States and the Chinese Communist Party
- NewsTrump admin. unveils new rule to deny China's access to U.S. AI chipsBoth involve China, House Select Committee on Strategic Competition between the United States and the Chinese Communist Party
- NewsChina Has Become an Excuse To Crack Down on AI Freedom (opinion)Both involve China, House Select Committee on Strategic Competition between the United States and the Chinese Communist Party
- NewsChina Has Become an Excuse To Crack Down on AI FreedomBoth involve China, House Select Committee on Strategic Competition between the United States and the Chinese Communist Party
- NewsSTAT+: Most-favored nations policy makes drugmakers rethink launches abroadBoth involve Eli Lilly
- NewsCancer Vaccines Are Advancing. Can Regulators Keep Up?Both involve Merck
- NewsCancer Vaccines Are Advancing. Can Regulators Keep Up?Both involve Merck
About
- China
- House Select Committee on Strategic Competition between the United States and the Chinese Communist Party
- Merck